Axis Capital
🏅 Ranked #33 on IPO GuruTotal Reviews
34
All time
Apply Rate
6%
of all calls
Win Rate
100%
Apply calls with +ve listing
Avg Listing Gain
+40.7%
on apply/may apply calls
Avg Total Gain
+65.8%
on apply/may apply calls
Performance Dashboard
Less than 5 reviews in last 12 months. Not enough data to rank yet.
Based on 2 reviews in the last 12 months.
How is this calculated?Accuracy
0%
Return Quality
0%
Consistency
0%
Horizon
0%
⚠️ Disclaimer: Past results are not guaranteed for future. This score reflects the last 1 year only. Use for research purposes only.
Verdict Breakdown (All Time)
Review History
Track record of Axis Capital
| IPO Name | Verdict | Total Gain | Report |
|---|---|---|---|
|
Not Rated | — | |
|
Not Rated | +43.9% | |
|
Not Rated | +11.2% | |
|
Not Rated | +14.9% | |
|
Apply | +78.8% | |
|
Not Rated | +7.3% | |
|
Not Rated | -0.4% | |
|
Apply | +52.8% | |
|
Not Rated | -45.1% | |
|
Not Rated | -26.3% | |
|
Not Rated | +17.5% | |
|
Not Rated | +7.4% | |
|
Not Rated | +75.4% | |
|
Not Rated | +4.1% | |
|
Not Rated | -2.3% | |
|
Not Rated | -12.3% | |
|
Not Rated | +35.0% | |
|
Not Rated | +45.3% | |
|
Not Rated | +45.4% | |
|
Not Rated | +17.0% |
Frequently Asked Questions
Is Axis Capital SEBI registered?
Yes, Axis Capital is a SEBI registered Research Analyst. SEBI registration means the analyst is regulated by the Securities and Exchange Board of India and authorised to publish investment research.
How many IPO reviews has Axis Capital given?
Axis Capital has reviewed 34 IPOs in total. The apply rate across all calls is 6%.
What is Axis Capital's IPO recommendation win rate?
Axis Capital has a 100% win rate — 100% of their Apply calls resulted in a positive listing gain on the NSE/BSE. The average listing gain on Apply calls is +40.7%.
Where can I read Axis Capital's IPO recommendations?
All IPO reviews by Axis Capital are listed on this page. You can filter by the last 12 months or all-time, and view the verdict (Apply / May Apply / Neutral / Avoid) alongside the actual listing and current gains for each IPO.